Safety and Immunogenicity of Revaccination with Influenza Vaccine in Healthy Adult Subjects aged 18 to 64 Years who were Previously Vaccinated with Fluzone ID or Fluzone IM

Project Details

StatusFinished
Effective start/end date11/09/0931/08/10

Funding

  • Sanofi Pasteur, Inc.: $127,350.00

Keywords

  • Biotechnology & Drug Development